Cleveland Clinic Study Finds AI can Develop Treatments to Prevent "Superbugs"

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the bacteria grow given certain perturbations. A team led by Jacob Scott, MD, PhD, and his lab in the Theory Division of Translational Hematology and Oncology, recently published their findings in PNAS.

Antibiotics are credited with increasing the average US lifespan by almost ten years. Treatment lowered fatality rates for health issues we now consider minor – like some cuts and injuries. But antibiotics aren't working as well as they used to, in part because of widespread use.

"Health agencies worldwide agree that we're entering a post-antibiotic era," explains Dr. Scott. "If we don't change how we go after bacteria, more people will die from antibiotic-resistant infections than from cancer by 2050."

Bacteria replicate quickly, producing mutant offspring. Overusing antibiotics gives bacteria a chance to practice making mutations that resist treatment. Over time, the antibiotics kill all the susceptible bacteria, leaving behind only the stronger mutants that the antibiotics can't kill.

One strategy physicians are using to modernize the way we treat bacterial infections is antibiotic cycling. Healthcare providers rotate between different antibiotics over specific time periods. Changing between different drugs gives bacteria less time to evolve resistance to any one class of antibiotic. Cycling can even make bacteria more susceptible to other antibiotics.

"Drug cycling shows a lot of promise in effectively treating diseases," says study first author and medical student Davis Weaver, PhD. "The problem is that we don't know the best way to do it. Nothing's standardized between hospitals for which antibiotic to give, for how long and in what order."

Study co-author Jeff Maltas, PhD, a postdoctoral fellow at Cleveland Clinic, uses computer models to predict how a bacterium's resistance to one antibiotic will make it weaker to another. He teamed up with Dr. Weaver to see if data-driven models could predict drug cycling regimens that minimize antibiotic resistance and maximize antibiotic susceptibility, despite the random nature of how bacteria evolve.

Dr. Weaver led the charge to apply reinforcement learning to the drug cycling model, which teaches a computer to learn from its mistakes and successes to determine the best strategy to complete a task. This study is among the first to apply reinforcement learning to antibiotic cycling regiments, Drs. Weaver and Maltas say.

"Reinforcement learning is an ideal approach because you just need to know how quickly the bacteria are growing, which is relatively easy to determine," explains Dr. Weaver. "There's also room for human variations and errors. You don't need to measure the growth rates perfectly down to the exact millisecond every time."

The research team's AI was able to figure out the most efficient antibiotic cycling plans to treat multiple strains of E. coli and prevent drug resistance. The study shows that AI can support complex decision-making like calculating antibiotic treatment schedules, Dr. Maltas says.

Dr. Weaver explains that in addition to managing an individual patient's infection, the team's AI model can inform how hospitals treat infections across the board. He and his research team are also working to expand their work beyond bacterial infections into other deadly diseases.

"This idea isn't limited to bacteria, it can be applied to anything that can evolve treatment resistance," he says. "In the future we believe these types of AI can be used to to manage drug-resistant cancers, too."

Weaver DT, King ES, Maltas J, Scott JG.
Reinforcement learning informs optimal treatment strategies to limit antibiotic resistance.
Proc Natl Acad Sci U S A. 2024 Apr 16;121(16):e2303165121. doi: 10.1073/pnas.2303165121

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...